These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36215089)

  • 41. Personalized medicine: a pediatric perspective.
    Arnold D; Jones BL
    Curr Allergy Asthma Rep; 2009 Nov; 9(6):426-32. PubMed ID: 19814914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
    Siamoglou S; Koromina M; Moy FM; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Jan; 25(1):52-59. PubMed ID: 33170085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Personalized medicine in the care of the child with congenital heart disease: discovery to application.
    Binesh Marvasti T; D'Alessandro LC; Manase D; Papaz T; Mital S
    Congenit Heart Dis; 2013; 8(3):266-9. PubMed ID: 23601919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.
    Aghaei Meybodi HR; Hasanzad M; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):166-174. PubMed ID: 28282717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
    Ahmed Z
    Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Finding Out What Matters in Decision-Making Related to Genomics and Personalized Medicine in Pediatric Oncology: Developing Attributes to Include in a Discrete Choice Experiment.
    McCarthy MC; De Abreu Lourenco R; McMillan LJ; Meshcheriakova E; Cao A; Gillam L
    Patient; 2020 Jun; 13(3):347-361. PubMed ID: 32037479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenomics and pharmacoepigenomics in pediatric medicine.
    Shastry BS
    Methods Mol Biol; 2014; 1175():671-85. PubMed ID: 25150880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent approaches in clinical applications of 3D printing in neonates and pediatrics.
    V S S; Panigrahy N; Rath SN
    Eur J Pediatr; 2021 Feb; 180(2):323-332. PubMed ID: 33025224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of the clinician in the multi-omics era: are you ready?
    van Karnebeek CDM; Wortmann SB; Tarailo-Graovac M; Langeveld M; Ferreira CR; van de Kamp JM; Hollak CE; Wasserman WW; Waterham HR; Wevers RA; Haack TB; Wanders RJA; Boycott KM
    J Inherit Metab Dis; 2018 May; 41(3):571-582. PubMed ID: 29362952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacogenetics and application in pediatrics.
    Neyro V; Jacqz-Aigrain E; Adam de Beaumais T
    Therapie; 2018 Apr; 73(2):157-163. PubMed ID: 29530313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obesity Genes, Personalized Medicine, and Public Health Policy.
    Caulfield T
    Curr Obes Rep; 2015 Sep; 4(3):319-23. PubMed ID: 26627489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent Advances and Emerging Applications in Text and Data Mining for Biomedical Discovery.
    Gonzalez GH; Tahsin T; Goodale BC; Greene AC; Greene CS
    Brief Bioinform; 2016 Jan; 17(1):33-42. PubMed ID: 26420781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomics, transcriptomics, proteomics and big data analysis in the discovery of new diagnostic markers and targets for therapy development.
    Park DI
    Prog Mol Biol Transl Sci; 2020; 173():61-90. PubMed ID: 32711818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response to "personalized medicine, genomics, and pharmacogenomics".
    Mayer DK
    Clin J Oncol Nurs; 2014 Dec; 18(6):618. PubMed ID: 25427694
    [No Abstract]   [Full Text] [Related]  

  • 57. Detecting Personalized Determinants During Drug Treatment from Omics Big Data.
    Wang L; Yu X; Zhang C; Zeng T
    Curr Pharm Des; 2018; 24(32):3727-3738. PubMed ID: 30398110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenomics in pediatric medicine and drug development.
    Schreeck F; Ahne G; Tremmel R; Schaeffeler E; Schwab M
    Pharmacogenomics; 2022 Aug; 23(13):709-712. PubMed ID: 36004680
    [No Abstract]   [Full Text] [Related]  

  • 59. Integrated in a systems pharmacology approach, pharmacogenetics holds the promise for personalized medicine in neonates.
    Allegaert K
    Pharmacogenomics; 2022 Aug; 23(12):667-670. PubMed ID: 35929406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.